Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
biochemical pharmacology; biomarkers; biosynthetics; chromosome; DNA structure; epigenetics; genetics; genomics; histology; individually tailored therapy; medicinal chemistry; medicine; membrane proteins; membrane transport; molecular biology; molecular pharmacology; pathophysiology; pharmacy; physiology; population genetics; proteomics; RNA structure; signal transduction; stem cells; transcriptional analyses; transgenic techniques; translational analyses
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Antimicrobial and Antiviral Drugs Discovery (Deadline: 30 September 2023)
- Epigenetics and Beyond: New Advances in Drug Discovery (Deadline: 30 September 2023)
- Rational Design and Synthesis of Bioactive Molecules (Deadline: 30 September 2023)
- Advances in the Design of Hydrogels for Therapeutic Agent and Cell Delivery (Deadline: 30 September 2023)
- Novel Mechanisms of Bacterial Antibiotic Resistance and Strategies to Fight Them (Deadline: 30 September 2023)
- Latest Advancements in Aging and Longevity: Is There a Role for Precision Medicine? (Deadline: 30 September 2023)
- Molecular Advances on Cannabinoid and Endocannabinoid Research 2.0 (Deadline: 30 September 2023)
- Permeation Enhancers and Other Strategies to Overcome Skin and Mucosal Barriers (Deadline: 30 September 2023)
- Optimizing New Therapeutic Targets for the Treatment of Chronic Pain (Deadline: 30 September 2023)
- Molecular Aspects of Medicinal Plants as Cancer Therapies (Deadline: 30 September 2023)
- New Advances in the Development of Anti-inflammatory Drugs (Deadline: 30 September 2023)
- Novel Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression (Deadline: 30 September 2023)
- Recent Research on Novel Lipid-Based Nano Drug Delivery Systems (Deadline: 30 September 2023)
- Novel Approaches for Topical or Transdermal Delivery of Large Molecules (Deadline: 15 October 2023)
- Drug Metabolism and Drug-Induced Liver Injury (Deadline: 15 October 2023)
- Proteomics and Nanotechnology for Medical and Pharmacological Applications (Deadline: 20 October 2023)
- Drugs in Inflammatory Bowel Diseases (Deadline: 25 October 2023)
- Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies 2.0 (Deadline: 25 October 2023)
- The Future of Drug Discovery and Development (Deadline: 30 October 2023)
- Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis 2.0 (Deadline: 30 October 2023)
- Natural Bioactive Compounds for Human Health 2.0 (Deadline: 30 October 2023)
- Novel Antimicrobial Agents (Deadline: 30 October 2023)
- Natural Products and Derivatives for the Management of Inflammatory Conditions (Deadline: 31 October 2023)
- Molecular Pharmacology of Cardiovascular Disease (Deadline: 31 October 2023)
- Research on Peptide-Drug Conjugates and Their Targets in Cancer Therapies (Deadline: 31 October 2023)
- Bioactive Compounds and Health 2.0 (Deadline: 31 October 2023)
- Cancer Therapeutic Targets and Drug Design (Deadline: 31 October 2023)
- Drug Delivery Systems: Current Status in the Treatment of Human Diseases (Deadline: 31 October 2023)
- Synergistic Properties of Selected Compounds with Antibiotics—Spectroscopic and Biological Studies (Deadline: 31 October 2023)
- Innovative Drugs Targeting Ion Channels (Deadline: 31 October 2023)
- Advancements on Antidepressant Substances, Medications and Therapies (Deadline: 31 October 2023)
- Development and Synthesis of Biologically Active Compounds (Deadline: 31 October 2023)
- Antiviral Drug Discovery (Deadline: 31 October 2023)
- The Role of Natural Bioactive Compounds in Healthy Aging and Regenerative Medicine (Deadline: 31 October 2023)
- Emerging Topics in Metal Complexes: Pharmacological Activity (Deadline: 15 November 2023)
- Innovative Approaches to Understand, Prevent and Eradicate Biofilms and Related Infections—a New Look from Natural Compounds to Nanotechnology (Deadline: 15 November 2023)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity, 3rd Edition (Deadline: 15 November 2023)
- Recent Therapeutic Strategies against Infectious Agents (Deadline: 15 November 2023)
- Mitochondrial Medicine: Pharmacological Targeting of Mitochondria in Disease (Deadline: 20 November 2023)
- Molecular Pharmacology in Diabetes 2.0 (Deadline: 30 November 2023)
- Recent Advances: Heterocycles in Drugs and Drug Discovery 2.0 (Deadline: 30 November 2023)
- Pharmacological Modulation of Oxidative Stress (Deadline: 30 November 2023)
- Developments in Drug Discovery: Computational and Experimental Aspects 2.0 (Deadline: 30 November 2023)
- Small Interfering RNAs, Antisense Drugs and Therapeutic Oligonucleotide Analogues (Deadline: 30 November 2023)
- Protein-Protein Interactions as Druggable Targets: Recent Advances (Deadline: 30 November 2023)
- Future Perspectives of Cell-Based Research in Toxicology and Drug Discovery (Deadline: 30 November 2023)
- Novel Strategies in the Development of New Anti-inflammatory Drug Substances and Therapies (Deadline: 30 November 2023)
- Towards Next-Frontier Patients-on-Chip as In Vitro Avatars for Personalised Medicine (Deadline: 30 November 2023)
- Tryptophan in Nutrition and Health 3.0 (Deadline: 30 November 2023)
- Recent Advances in the Pharmacology of Spinocerebellar Ataxia (Deadline: 30 November 2023)
- Bioactive Organic Compounds Acting in Mitochondria (Deadline: 30 November 2023)
- Natural Products as Multitarget Agents in Human Diseases (Deadline: 30 November 2023)
- Recent Advances in Drug Nanocarriers and Targeted Delivery Systems: From Liposomes to Block Copolymer Micelles (Deadline: 30 November 2023)
- Advanced Synthetic Methodologies in Drug Development (Deadline: 30 November 2023)
- Antiviral Activity of Lectins (Deadline: 30 November 2023)
- Advances in Anti-inflammatory Drug Development (Deadline: 30 November 2023)
- Molecular Pharmacology of Antidepressants (Deadline: 30 November 2023)
- Multi-Target Directed Ligands in Drug Development (Deadline: 15 December 2023)
- Natural Products and Synthetic Compounds for Drug Development (Deadline: 15 December 2023)
- Carbohydrate Structures in Targeted Drug Delivery (Deadline: 15 December 2023)
- Inositol in Translational Medicine (Deadline: 15 December 2023)
- Pharmacological Activities of Secondary Metabolites and Derivates of Medicinal Plants around the World (Deadline: 15 December 2023)
- Pharmacology of Metformin—Its Molecular Mechanisms Underlying Versatile Cellular Responses (Deadline: 30 December 2023)
- Computational Medicine and Molecular Drug Design (Deadline: 30 December 2023)
- Recent Highlights of Isatin-Based Hybrids as Promising Pharmacological Agents (Deadline: 30 December 2023)
- Protein-Protein and Protein-DNA Interactions in Drug Discovery (Deadline: 30 December 2023)
- Thioredoxin Reductase: Signaling Pathways and Pharmacological Targets (Deadline: 30 December 2023)
- Mass Spectrometry Imaging for Drug Pharmacokinetics and Drug Delivery System (Deadline: 30 December 2023)
- Micro and Nanosystems for Drug Delivery (Deadline: 30 December 2023)
- Molecular Targets for Antiviral and Anticancer Drugs (Deadline: 30 December 2023)
- Current Advances in Metal Complexes with Biological Activity (Deadline: 30 December 2023)
- Anti-cancer Effects of Natural Products (Deadline: 31 December 2023)
- Liposomes as Membrane Models in Drug-Lipid Interactions (Deadline: 31 December 2023)
- Current Research in Pharmacognosy: A Focus on Biological Activities (Deadline: 31 December 2023)
- Molecular Insights into Drug Development for Alzheimer’s Disease (Deadline: 31 December 2023)
- New Insight into Anticoagulants (Deadline: 31 December 2023)
- Antiviral Drug Targets: Structure, Function, and Drug Design 2.0 (Deadline: 31 December 2023)
- Biochemical and Molecular Changes in the Brain Caused by Drug Abuse: Implications for Therapeutic Intervention (Deadline: 31 December 2023)
- Topoisomerase Inhibitors: Future Perspectives and Challenges (Deadline: 31 December 2023)
- Updates and New Concepts in CNS Drug Delivery (Deadline: 31 December 2023)
- Overcoming Biological Barriers: Importance of Membrane Transporters in Homeostasis, Disease, and Disease Treatment 2.0 (Deadline: 31 December 2023)
- Endogenous Gaseous Signaling Molecules: Their Mechanism(s) of Action and Pharmacological Effects 2.0 (Deadline: 31 December 2023)
- Molecular Computer Science and Artificial Intelligence for Drug Discovery (Deadline: 31 December 2023)
- 60th Anniversary from Indomethacin Approval: New Insights into the Mechanism of Action (Deadline: 31 December 2023)
- State-of-the-Art Molecular Pharmacology in Spain 2.0 (Deadline: 31 December 2023)
- Pharmacogenetics and Personalized Medicine 3.0 (Deadline: 31 December 2023)
- Application of Natural Products in Biomedicine and Pharmacotherapy (Deadline: 31 December 2023)
- Nutrients, Natural Products and Nanoparticles for the Development of New Therapeutic Agents (Deadline: 31 December 2023)
- Cyclic and Heterocyclic Compounds in Drug Synthesis and Delivery (Deadline: 31 December 2023)
- Cancer Cell Models for Development of Anti-cancer Drugs 2.0 (Deadline: 31 December 2023)
- Medicinal Plants as a Source of Novel Drug Products (Deadline: 31 December 2023)
- G Protein-Coupled Receptors: Signaling, Regulation and Therapeutic Opportunities (Deadline: 15 January 2024)
- New Agents and Novel Drugs Use for the Oncological Diseases Treatment (Deadline: 20 January 2024)
- Comeback to Natural Therapeutics in Modern Age: Insights into Molecular Modes of Action of Natural Products 2.0 (Deadline: 25 January 2024)
- The Discovery and Development of Cisplatin 2.0 (Deadline: 28 January 2024)
- Novel PET Radiopharmaceuticals: Molecular Probes for Personalized Imaging 2.0 (Deadline: 30 January 2024)
- New Insights of Main-Group and Transition Metal Compounds in Medicinal Chemistry (Deadline: 30 January 2024)
- Synthesis and Biological Evaluation of Pyrazole Derivatives (Deadline: 31 January 2024)
- Nutrients and Natural Agents as Drug Leads for Product Development (Deadline: 31 January 2024)
- Drug Treatment for Bacterial Infections (Deadline: 31 January 2024)
- Effect of Cardioprotective Drugs on the Cardiovascular System (Deadline: 31 January 2024)
- Redox Regulation and Drug Discovery (Deadline: 31 January 2024)
- Medicinal Plants and Natural Compounds in Health and Disease: Progresses, Challenges, Opportunities (Deadline: 31 January 2024)
- Advances in Protein-Protein Interactions 2.0 (Deadline: 31 January 2024)
- Cell Energetics and Ascorbic Acid: Cancer Treatment with Vitamin C (Deadline: 15 February 2024)
- Cutting-Edge Research on Antiviral Therapy (Deadline: 15 February 2024)
- Advances in Drug Discovery and Synthesis (Deadline: 15 February 2024)
- Computational Pharmacology in Drug Discovery (Deadline: 20 February 2024)
- Molecular Pharmacology of Human Metabolism Diseases (Deadline: 28 February 2024)
- Recent Progress of Opioid Research 2.0 (Deadline: 28 February 2024)
- Advances in Pharmacology of Prostaglandins (Deadline: 28 February 2024)
- Biomarkers and Drug Targets for Longevity (Deadline: 29 February 2024)
- Antifungal Drug Discovery: Progresses, Challenges, Opportunities (Deadline: 29 February 2024)
- Bioactive Substances of Plant Origin and Their Pharmacological Effects (Deadline: 29 February 2024)
- Metal-Based Drugs and Research on Mechanisms of Action (Deadline: 20 March 2024)
- New Insights into Anti-cancer Drug Discovery and Development (Deadline: 28 March 2024)
- Molecular Mechanisms and Pharmacological Approaches for Brain Injury (Deadline: 30 March 2024)
- Techniques and Strategies in Drug Design and Discovery, 2nd Edition (Deadline: 30 March 2024)
- Coordination Compounds as Diagnostic, Therapeutic and Theranostic Agents (Deadline: 30 March 2024)
- Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 3.0 (Deadline: 30 March 2024)
- Precision Medicine for Oral Diseases and Cancers (Deadline: 30 March 2024)
- Recent Research on Antimicrobial Agents (Deadline: 31 March 2024)
- Innovative Solutions in Pharmacokinetics and Translational Research (Deadline: 31 March 2024)
- New Drugs Regulating Cytoskeletons in Human Health and Diseases (Deadline: 31 March 2024)
- Drug Discovery and Application of New Technologies (Deadline: 31 March 2024)
- Protein Structure-Function Relationships and Inhibition: From Molecular Insights to Therapeutic Applications (Deadline: 30 April 2024)
- Advanced Research on N-chlorotaurine and Other Active Halogen Taurine Derivatives (Deadline: 30 June 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
